新型减肥疗法对心血管的影响
Muhammad Shariq Usman1,2, Melanie Davies3,4, Michael E Hall5
1Department of Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
肥胖显著增加了心血管疾病的风险. 新的药理干预措施,如GLP-1激动剂,现在优先考虑心血管患者的体重管理,提供有效的减肥和改善结果.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 肥胖是一个全球性流行病,增加了2型糖尿病,高血压和心血管疾病 (CV) 的风险.
- 心脏病专家面临着管理CV患者肥胖的挑战,因为有效的药物治疗和专业知识有限.
- 肥胖率的上升可能会抵消心血管疾病预防方面的进展.
结论:
- 优化体重管理对于改善心血管健康至关重要.
- 整合药物治疗和生活方式的改变可以最大限度地提高心脏病益处.
- 这种方法旨在改善心血管疾病患者的整体福祉.
更多相关视频
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
06:28A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
相关概念视频
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hypertension IV: Drug Therapy and Lifestyle Modifications
